Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Neisseria gonorrhoeae Lipooligosaccharide (LOS) Antibody (3F11) - Galbeta1-4Glcnac, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP274993

Catalog No. NBP274993


Only null left
Add to Cart

Description

Description

Neisseria lipooligosaccharide (LOS) Monoclonal specifically detects Neisseria lipooligosaccharide (LOS) in Bacteria samples. It is validated for Western Blot, ELISA, Dot Blot.
Specifications

Specifications

Neisseria lipooligosaccharide (LOS)
Monoclonal
1 mg/ml
Western Blot, ELISA, Dot Blot
2-Acetamido-2-deoxy-4-O-beta-D-galactopyranosyl-D-glucopyranose, Gal-beta 1-4GlcNAc, LacNAc, N-Acetyl-4-O-(beta-D-galactopyranosyl)-D-glucosamine, N-Acetyl-D-Lactosamine
lactosamine (Galbeta1-4Glcnac) epitope found in lipooligosaccharide (LOS) of pathogenic Neisseria species
0.1 mL
Primary
Bacteria
IgM
Western Blot, ELISA, Dot Blot
3F11
Unconjugated
PBS with 0.02% Sodium Azide
Mouse
Thiophilic Chromatography
Immunology, Virology Bacteria and Parasites
Shown to recognize common antigenic region in gonococcal lipopolysaccharide (LPS). Recognizes conserved region on 6 different different gonococcal serotypes (90% of gonococci can be typed to 1 of these 6 serotypes)
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.